Minimal-trauma fracture in women with breast cancer surviving for at least 5 years from diagnosis

[1]  J. Eisman,et al.  Relationship Between Body Mass Index and Fracture Risk Is Mediated by Bone Mineral Density , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  F. Cardoso,et al.  Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  Jamlik-Omari Johnson,et al.  The diagnostic utility of rib series in assessing rib fractures , 2014, Emergency Radiology.

[4]  S. Davis,et al.  Patterns of use of oral adjuvant endocrine therapy in Australian breast cancer survivors 5 years from diagnosis , 2013, Menopause.

[5]  B. Clarke.  Fracture Risk in Women With Breast Cancer: A Population-Based Study , 2012 .

[6]  Purushottam W. Laud,et al.  Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patients , 2011, Osteoporosis International.

[7]  J. Griggs,et al.  American society of clinical oncology clinical practice guideline update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. , 2010, Journal of oncology practice.

[8]  C. Ribot,et al.  Bone mineral density and prediction of non-osteoporotic disease. , 2010, Maturitas.

[9]  M. Castiglione,et al.  Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  M. Beckmann,et al.  Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  A. Howell,et al.  Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group. , 2008, Cancer treatment reviews.

[12]  Rory Wolfe,et al.  Use of a cancer registry is preferable to a direct-to-community approach for recruitment to a cohort study of wellbeing in women newly diagnosed with invasive breast cancer , 2008, BMC Cancer.

[13]  A. M. López,et al.  Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study. , 2005, Archives of internal medicine.

[14]  M Baum,et al.  Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer , 2005, The Lancet.

[15]  J. Eisman,et al.  Symptomatic fracture incidence in elderly men and women: The Dubbo osteoporosis epidemiology study (DOES) , 1994, Osteoporosis International.

[16]  J. Eisman,et al.  Incidence of Hip and Other Osteoporotic Fractures in Elderly Men and Women: Dubbo Osteoporosis Epidemiology Study , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  G. Tell,et al.  Risk factors for low bone mineral density among a large group of Norwegian women with fractures , 2000, European Journal of Epidemiology.

[18]  J. Cauley,et al.  American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  G. Jones,et al.  A Population-Based Study of Fracture Incidence in Southern Tasmania: Lifetime Fracture Risk and Evidence for Geographic Variations within the Same Country , 2001, Osteoporosis International.

[20]  J. Pasco,et al.  Age- and Gender-Specific Rate of Fractures in Australia: A Population-Based Study , 1999, Osteoporosis International.

[21]  M. Overgaard.  Spontaneous radiation-induced rib fractures in breast cancer patients treated with postmastectomy irradiation. A clinical radiobiological analysis of the influence of fraction size and dose-response relationships on late bone damage. , 1988, Acta oncologica.